Global ETF Survey 2026: Answer now →
Help us improve your experience. Please confirm your investor type:
The ETF Industry Is Evolving Fast
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.
PPH ETF · VanEck Pharmaceutical ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +6.09% | +3.72% | +24.67% | +47.99% | +61.99% | -0.81% | -0.81% | +6.09% | |
| Flows |
Key fund info
Essentials
Enterprise
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +3.72% | +24.67% | +47.99% | +61.99% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
Replication
Issuer
| AuM | ||
|---|---|---|
SMH | VanEck Semiconductor ETF | €64.41B |
GDX | VanEck Gold Miners ETF | €19.93B |
MOAT | VanEck Morningstar Wide Moat ETF | €10.32B |
SMGB | VanEck Semiconductor UCITS ETF | €8.18B |
TDIV | VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF | €8.11B |
Through forward-looking, intelligently designed active and ETF solutions, VanEck offers value-added exposures to emerging industries, asset classes and markets as well as differentiated approaches to traditional strategies. Global player based in New York, founded in 1955, ranked among the 10 best providers of ETFs in the United States, VanEck also has a strong presence in Europe (Germany, Switzerland, the Netherlands) as well as a presence in Asia and Australia. VanEck is different from other asset managers by being privately held, allowing them to focus on clients’ long-term interests, constantly been at the forefront of innovation and whose ETFs are transparent with no synthetic replication and no lent out.
Via Offical websiteFrequently asked questions about PPH
What does VanEck Pharmaceutical ETF, PPH, invest in?
PPH is a Passive ETF. This ETF provides exposure to Pharmaceuticals Equities.
Which benchmark or index does PPH replicate?
PPH tracks the MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of PPH?
PPH carries a total expense ratio (TER) of 0.36%, indicating the annual cost for holding the fund.
When was PPH launched?
PPH was introduced to the market on December 20, 2011. It trades on United States
Who is the ETF issuer of PPH?
VanEck Pharmaceutical ETF, PPH, is provided by VanEck. Learn more about VanEck here.
What is the current assets under management (AUM) of PPH?
PPH oversees €810M in assets as of July 1, 2026.
How has PPH performed lately?
Based on data from July 1, 2026, PPH returned 6.09% over the past month, 3.72% over the last three months and 6.09% year-to-date.
What are the latest inflows or outflows for PPH?
As of July 1, 2026, PPH recorded net flows of -€40M over the last month and -€339M year-to-date.
Does PPH distribute dividends?
PPH follows a distributing dividend policy, meaning it pays out income to investors. As of July 1, 2026, its 12-month trailing yield was 2.01%.
What are the main country or region exposures of PPH?
As of May 31, 2026, PPH has significant geographic allocations in USA, United Kingdom and Switzerland.
In which sector or theme does PPH invest in?
As of May 31, 2026, PPH focuses largely on Healthcare.
How many securities does PPH hold and how diversified is it?
As of May 31, 2026, PPH holds 25 positions in its portfolio, with 91.18% of assets concentrated in its top 15 holdings.
What are the main positions in PPH?
As of May 31, 2026, PPH top three holdings include Eli Lilly & Co., Novartis AG and Merck & Co., Inc..
What is the base currency of PPH?
The base currency of PPH is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
